BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed EWTX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:6ee31ec3b7174c3e2b3f@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:EWTX P2 readout (est.): A Study of EDG-5506 in Children With Duchen
 ne Muscular Dystrophy (LYNX)
DESCRIPTION:A Study of EDG-5506 in Children With Duchenne Muscular Dystroph
 y (LYNX)\nNCT05540860 | PHASE2 | ACTIVE_NOT_RECRUITING | sponsor: Edgewise
  Therapeutics\, Inc.\nPrimary completion date (ESTIMATED)\; top-line resul
 ts usually follow later.\nDate precision: month (shown on the first day)\n
 Ticker EWTX (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT
 05540860\nScheduling/reference data from public records\; dates can move. 
 Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05540860
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
